Avanos Medical (AVNS)
NYSE:AVNS
Want to see AVNS full AI Analyst Report?
Total Valuation
Avanos Medical has a market cap or net worth of $1.16B. The enterprise value is $1.23B.
Market Cap$1.16B
Enterprise Value$1.23B
Share Statistics
Avanos Medical has 46,824,795 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,824,795
Owned by Insiders1.95%
Owned by Institutions27.36%
Financial Efficiency
Avanos Medical’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -6.65%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.06
Return on Invested Capital (ROIC)-6.65%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee314.86K
Profits Per Employee-32.73K
Employee Count2,227
Asset Turnover0.65
Inventory Turnover2.38
Valuation Ratios
The current PE Ratio of Avanos Medical is 31.9. Avanos Medical’s PEG ratio is 0.09.
PE Ratio31.9
PS Ratio0.74
PB Ratio0.67
Price to Fair Value0.67
Price to FCF12.09
Price to Operating Cash Flow31.28
PEG Ratio0.09
Income Statement
In the last 12 months, Avanos Medical had revenue of 701.20M and earned -67.90M in profits. Earnings per share was -1.46.
Revenue701.20M
Gross Profit349.00M
Operating Income-61.60M
Pretax Income-66.20M
Net Income-67.90M
EBITDA-33.20M
Earnings Per Share (EPS)-1.46
Cash Flow
In the last 12 months, operating cash flow was 36.70M and capital expenditures -29.20M, giving a free cash flow of 7.50M billion.
Operating Cash Flow36.70M
Free Cash Flow7.50M
Free Cash Flow per Share0.16
Dividends & Yields
Avanos Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.29
52-Week Price Change94.80%
50-Day Moving Average19.66
200-Day Moving Average13.99
Relative Strength Index (RSI)87.32
Average Volume (3m)533.25K
Important Dates
Avanos Medical upcoming earnings date is Aug 11, 2026, Before Open (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateAug 11, 2026
Ex-Dividend Date―
Financial Position
Avanos Medical as a current ratio of 2.15, with Debt / Equity ratio of 17.70%
Current Ratio2.15
Quick Ratio1.26
Debt to Market Cap0.19
Net Debt to EBITDA-1.18
Interest Coverage Ratio-15.40
Taxes
In the past 12 months, Avanos Medical has paid 1.70M in taxes.
Income Tax1.70M
Effective Tax Rate-0.03
Enterprise Valuation
Avanos Medical EV to EBITDA ratio is -16.88, with an EV/FCF ratio of 13.00.
EV to Sales0.80
EV to EBITDA-16.88
EV to Free Cash Flow13.00
EV to Operating Cash Flow7.50
Balance Sheet
Avanos Medical has $65.60M in cash and marketable securities with $138.40M in debt, giving a net cash position of -$72.80M billion.
Cash & Marketable Securities$65.60M
Total Debt$138.40M
Net Cash-$72.80M
Net Cash Per Share-$1.55
Tangible Book Value Per Share$5.72
Margins
Gross margin is 48.55%, with operating margin of -8.78%, and net profit margin of -9.68%.
Gross Margin48.55%
Operating Margin-8.78%
Pretax Margin-9.44%
Net Profit Margin-9.68%
EBITDA Margin-4.73%
EBIT Margin-8.87%
Analyst Forecast
The average price target for Avanos Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast3.87%
EPS Growth Forecast80.78%